Financial instruments - Schedule of Fair Value Adjustment (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Contingent consideration derivative liabilities | ||||
| Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||
| Unrealized (gain) loss | $ 12,004 | $ (3,830) | $ 6,757 | $ (6,205) |
| Embedded contingent interest derivative | ||||
| Fair Value Measurement Inputs and Valuation Techniques [Line Items] | ||||
| Unrealized (gain) loss | $ (671) | $ (1,597) | $ (1,970) | $ 2,126 |
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|